-transparent.png){kind=logo}
Twenty five patients with gastric ulcer were prospectively studied. They were admitted during acute phase and given cimetidine, 1000 mg/day for 6 weeks. They were maintained on cimetidine (up to 800 mg/day) for another 12 week period. The patients were studied with laboratory tests, endoscopy and biopsy during 4 steps of follow-up. A 76% healing rate was noted during the study. The incidence of side effects was low and drug tolerance and efficacy was shown to be good.
Related Publications
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
January 1980,
Arquivos de gastroenterologia,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
February 1979,
Lakartidningen,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
November 1978,
British medical journal,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
January 1979,
Revista espanola de las enfermedades del aparato digestivo,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
May 1982,
Gastrointestinal endoscopy,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
January 1980,
Revista clinica espanola,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
February 1978,
Gastroenterology,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
January 1987,
Revista de gastroenterologia de Mexico,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
January 1981,
Clinical therapeutics,
R Mascarenhas e Silva, and
I Barbosa Sobrinho, and
R S Fernandes
February 1976,
Lancet (London, England),
